Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FGY39
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,976
Award facts
- Contract value 100% obligated
- $9,975.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,975.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on May 12, 2025, with completion scheduled for June 3, 2025. This competitive award, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems.
Benlysta (belimumab) is a biologic immunosuppressant medication used to treat systemic lupus erythematosus and other autoimmune conditions. This delivery order reflects AmerisourceBergen's established role as a prime vendor within DLA's pharmaceutical supply chain, which encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates consistent competitively awarded arrangements with firm fixed pricing, positioning it as a key supplier for Defense Health Agency and U.S. Coast Guard medical operations requiring reliable access to specialized therapeutics.
Quick answers
Who was awarded contract SPE2DB25FGY39?
SPE2DB25FGY39 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FGY39 worth?
The government has obligated $9,976 on SPE2DB25FGY39.
Is contract SPE2DB25FGY39 an order under another contract?
Yes. SPE2DB25FGY39 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGY39 competed?
The extent of competition for SPE2DB25FGY39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award